Analysis of the cellular centrosome in fine-needle aspirations of the breast
2007

Centrosome Analysis in Breast Tumors

Sample size: 100 publication Evidence: moderate

Author Information

Author(s): Guo Hui-qin, Gao Meixia, Ma Jinfang, Xiao Ting, Zhao Lin-lin, Gao Yanning, Pan Qin-jing

Primary Institution: Cancer Institute/Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences

Hypothesis

Are centrosome amplifications present in breast tumor cells, and can centrosomal analysis aid in the diagnosis and prognosis of breast carcinoma?

Conclusion

Structural centrosome amplification may be a potential biomarker for the diagnosis and prognosis of breast carcinoma.

Supporting Evidence

  • Centrosome amplifications were found in most breast tumors.
  • Cells with numerical centrosome amplification were found in 23 of 25 benign lesions and in all 75 cases of breast carcinomas.
  • Structural centrosome amplification was found in 69 of 75 breast carcinomas.
  • The mean percentage of cells with numerical centrosome amplification was significantly higher in breast carcinomas than in benign lesions.
  • Structural centrosome amplification was significantly associated with HER2/neu overexpression and negative estrogen receptor status.

Takeaway

The study looked at breast tumor cells to see if they had extra centrosomes, which could help doctors tell if a tumor is cancerous or not.

Methodology

Immunofluorescence analysis was used to evaluate centrosome abnormalities in fine-needle aspirations of 100 breast lesions.

Limitations

The study may need larger sample sizes for more definitive conclusions.

Participant Demographics

The study included 100 breast lesions, with 25 benign and 75 malignant cases.

Statistical Information

P-Value

P < 0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr1752

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication